Skip to content

Private Label vs Custom Formulation for Wellness Practitioners

Last reviewed: May 21, 2026 | Next review: November 21, 2026

By Greg Huang, founder since 2009 in the dietary supplement and nutrition industry

A practitioner who has been recommending supplements for years sits at a fork. One path picks an existing stock formula from a manufacturer's catalog, adds a custom label and packaging, and ships in weeks. The other path designs a new formula, runs pilot batches, conducts stability testing, and ships in months. Both paths produce a "practitioner-branded supplement." They are not equivalent commitments.

Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.

Two manufacturing paths, very different commitments

This guide compares the two paths for wellness service business owners. It assumes you already understand supplement quality fundamentals because you have been evaluating other brands for your patients. The question is not what makes a good supplement. The question is which path matches your practice stage, product idea, and capital position.

Private label, defined

Private label uses a contract manufacturer's existing stock formula. You select a formula from a catalog, customize within the manufacturer's allowed envelope (sometimes flavor or capsule color), and apply your own label and packaging. The manufacturer owns the formula. You license the right to sell it under your brand.

Most private label minimum order quantities run 100 to 500 units per SKU at the entry level, though some manufacturers require 1,000 to 5,000 units depending on product type. Lead times are typically 4 to 8 weeks from order to delivery, including label production. Starting costs range from $1,000 to $15,000 in total, with the lower end reserved for fully-stocked pre-formulated products and the upper end including custom packaging and modest branding.

Several manufacturers now position toward low MOQs specifically to serve solo practitioners and emerging brands. The trade-off is structural: a stock formula does not differentiate you from other brands selling the same base formula under different labels.

Custom formulation, defined

Custom formulation creates a new formula designed specifically for your brand. The process typically includes formulator consultation, ingredient sourcing, pilot batches, stability testing, and a defined intellectual property arrangement. The result is a formula that is yours, not licensed.

Custom formulation MOQs are higher. Most custom manufacturers set a MOQ of 2,500 to 5,000 units per SKU for capsules, tablets, or powder pouches. A startup MOQ order with basic custom formulation, setup, packaging, and compliance runs $20,000 to $40,000. Lead time runs 8 to 16 weeks or longer depending on stability requirements.

The defensibility argument runs the other direction. When a formula is yours and not on a stock catalog, patients searching the active ingredients online have fewer comparable options. Word-of-mouth referrals carry weight because the formula is associated with your practice.

Cost and timeline side by side

The honest framing is that private label and custom formulation are not competing for the same first launch dollar.

For a practitioner with strong patient demand for a specific product (digestive support, sleep support, electrolytes), private label answers the question of how fast you can have your own branded version on the shelf. The answer is typically 4 to 8 weeks at $1,000 to $15,000.

For a practitioner with a specific formula idea their patient base is asking for and that does not exist on stock catalogs, custom formulation answers a different question: what does it take to make this exact formula? The answer is 8 to 16 weeks at $20,000 to $40,000 for a first batch.

A guide that says custom formulation is always better, or private label is always better, is selling something. The right answer depends on which question you are asking.

When private label fits

Private label fits when your practice can use the SKU immediately, when stock formulas align reasonably with what you would prescribe, and when capital constraints push toward smaller first runs. It fits when you want to prove that patient-branded supplements work as a business model before committing $20,000 to a custom batch. It fits when your differentiation is your practice and your educational content, not the formula itself.

Private label does not fit when you want a formula that does not exist on stock catalogs. It does not fit when the active ingredients you care about are at concentrations no stock formula provides. It does not fit when the same formula appearing on a major marketplace next month under a different label creates a competitive problem for you.

When custom formulation fits

Custom formulation fits when you have a specific clinical or operational reason a stock formula will not work. It fits when you can absorb 2,500 to 5,000 units of first-run inventory through your practice and referral network within 12 to 18 months. It fits when your practice is established enough that paying for stability testing, IP protection, and longer lead times does not strain working capital.

Custom formulation does not fit as a first move when you have not yet validated demand for your specific product idea. Many practitioners assume their patients will buy whatever they recommend. Patients are loyal to practitioners, but they buy supplements based on price, ingredient familiarity, and convenience. Validating that loyalty translates to brand willingness is what a smaller first run does.

The graduation path most practitioners follow

A common pattern looks like this. The practitioner picks one or two stock formulas they would already prescribe, brands them, and stocks the practice dispensary or an online dispensary system. Inventory turns reveal which products patients actually buy versus what they say they will buy. After 6 to 12 months of data, the practitioner has clear evidence of which products warrant custom formulation investment and which do not. The custom batch then targets a known-good demand signal, not a guess.

This sequence reduces the cost of being wrong. It also reduces the cognitive load of running a new brand alongside an existing practice. The first private label SKUs are an operational experiment. The custom batch is a scale decision based on data the experiment produced.

Formula ownership and intellectual property

With private label, the manufacturer owns the formula. Other brands may sell the same stock formula under their own labels. Your differentiation is the brand, the practice, and the patient relationship.

With custom formulation, ownership depends on the contract. Most reputable custom manufacturing agreements include an IP ownership clause that grants the formula to the brand. Some manufacturing agreements retain joint ownership or grant the manufacturer rights to use the formula for other brands after a non-compete window. Read the contract. Verify ownership terms in writing before paying for formulation work.

For deeper detail on IP and formula ownership clauses, see the IR guide on private label vs custom formulation, which covers the legal mechanics in the broader supplement industry context. This guide focuses on the practitioner-channel implications.

Questions to ask before you commit

Before placing a first order with either path, get clear written answers on:

  • Minimum order quantity per SKU and whether MOQs reduce after the first run
  • Lead time from purchase order to delivered finished goods, including label production
  • Total all-in cost, including formulation fees, setup fees, ingredient costs, packaging, labeling, freight, and any compliance or testing fees
  • What testing the manufacturer performs on incoming raw materials and finished product (Certificate of Analysis scope and frequency)
  • Whether the manufacturer is FDA registered and operates under 21 CFR Part 111 cGMP
  • For custom formulation: written IP ownership clause and any non-compete window for the formula
  • For private label: how many other brands sell the same stock formula and whether geographic or category exclusivity is available

A manufacturer who hesitates on any of these is signaling something about their record-keeping or their priorities. That signal is useful information. For deeper detail on manufacturer evaluation, see our manufacturer evaluation guide.

Frequently asked questions

What is the cheapest path to a practitioner-branded supplement?

The cheapest path is pre-formulated private label using the manufacturer's standard catalog formula with a basic label. Total entry cost can be $1,000 to $3,000 if you handle branding in-house and use the manufacturer's standard packaging. The trade-off is no differentiation from other brands using the same stock formula.

Can I switch from private label to custom formulation later?

Yes, and many practitioner-led brands follow this exact path. Private label proves demand and operational fit. Custom formulation scales the demand the private label run validated. The intermediate step is sometimes a modified stock formula where the manufacturer adjusts an existing formula within their formulation envelope at modest extra cost.

Do I need a separate license to sell my own branded supplements?

You need to register with the FDA as a dietary supplement facility, or contract with a registered facility for production. Your existing healthcare license does not authorize supplement manufacturing or distribution. State licensing boards have varying guidance on practitioners selling supplements. Consult your board before launch.

Who is responsible if the manufacturer makes a contaminated batch?

Brand owners are responsible for product compliance under 21 USC. FDA guidance reinforces this: a brand that contracts with another firm for manufacturing is responsible for ensuring the product is not adulterated, regardless of who performs the manufacturing operations. Your quality agreement with the manufacturer defines how testing, recall responsibility, and disclosure work. Get the agreement reviewed before signing.

Should I use a manufacturer-provided sales channel or build my own?

The trade-off depends on your patient base. A manufacturer or platform that handles dispensing infrastructure removes operational overhead but limits margin. A practice-direct dispensary maximizes margin but requires you to handle inventory, shipping, returns, and dispensing-compliance. Many practitioners run both channels in parallel during transition.

Greg Huang, founder since 2009 in the dietary supplement and nutrition industry

Founder of Inventory Ready. Previously founded and operated multiple consumer brands in the dietary supplement and nutrition industry since summer 2009.

Ready to evaluate a contract manufacturer?

Tell us about your product concept and we'll help match you with assessed contract manufacturers for private label or custom formulation.